Back
AMN Healthcare Services 10K Form
Sell
28
AMN
AMN Healthcare Services
Last Price:
$19.51
Seasonality Move:
4.43%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-07 | 10Q | AMN/AMN Healthcare Services Quarterly |
2020-05-11 | 10Q | AMN/AMN Healthcare Services Quarterly |
2020-02-25 | 10K | AMN/AMN Healthcare Services Annual |
2019-11-04 | 10Q | AMN/AMN Healthcare Services Quarterly |
2019-08-07 | 10Q | AMN/AMN Healthcare Services Quarterly |
2019-05-03 | 10Q | AMN/AMN Healthcare Services Quarterly |
Receive AMN News And Ratings
See the #1 stock for the next 7 days that we like better than AMN
AMN Financial Statistics
Sales & Book Value
Annual Sales: | $3B |
---|---|
Cash Flow: | $56.6M |
Price / Cash Flow: | 3.05 |
Annual Sales: | $18.56 |
Price / Book: | 1.03 |
Profitability
EPS (TTM): | -3.85000 |
---|---|
Net Income (TTM): | $-147M |
Gross Margin: | $919.4M |
Return on Equity: | -17.67% |
Return on Assets: | -5.38% |
AMN Healthcare Services Earnings Forecast
Key AMN Healthcare Services Financial Ratios
-
The Gross Profit Margin over the past 25 years for AMN is 30.81%.
-
The Selling, General & Administrative Expenses for AMN have been equal to 21.20% of Gross Profit Margin.
-
The Net Earning history of AMN is -4.93% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 15 years.
AMN Healthcare Services Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Health Care Providers & Services |
Sector: | Health Care |
Current Symbol: | AMN |
CUSIP: | 001744 |
Website: | amnhealthcare.com |
Debt
Debt-to-Equity Ratio: | 1.49 |
---|---|
Current Ratio: | 1.09 |
Quick Ratio: | 0.97 |
Price-to-Earnings
Trailing P/E Ratio: | 4.82 |
---|---|
Forward P/E Ratio: | 11.54 |
AMN Technical Analysis vs Fundamental Analysis
Sell
28
AMN Healthcare Services (AMN)
is a Sell
Is AMN Healthcare Services a Buy or a Sell?
-
AMN Healthcare Services stock is rated a SellThe current AMN Healthcare Services [AMN] share price is $19.11. The Score for AMN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.